The role of amino acids in the amplification and quality of DNA vectors for industrial applications
- PMID: 31298810
- DOI: 10.1002/btpr.2883
The role of amino acids in the amplification and quality of DNA vectors for industrial applications
Abstract
In this study, we have demonstrated that the type and feeding regimen of amino acids have a significant impact on the quality as well as the quantity of DNA vectors produced. Nutrient pool and factorial design experiments were carried out in order to identify the amino acids involved in increased biomass and induction of plasmid amplification. Leucine, glycine, and histidine were responsible for increased biomass and leucine starvation in the presence of histidine was implicated in plasmid amplification. Supercoiling of the plasmid was optimized using a dual feeding strategy. As a result of this, a fed-batch fermentation strategy for the production of a 6.9 kb plasmid, pSVß, in Escherichia coli DH5α was developed. In batch fermentation, a maximum plasmid yield of 39.4 mg/L equivalent to 11.3 mg/g dry cell weight (DCW) was achieved with casein hydrolysate limitation. About 90% of plasmid was in the supercoiled (SC) form after 31 hr of fermentation but only remained so for a short period, leading to a very brief window for harvesting cells at scale. Subsequently, a fed-batch fermentation using a dual feeding strategy was employed. A mean maximum plasmid yield of 44 mg/L equivalent to 9.1 mg plasmid/g DCW was achieved. After 25 hr, 90% of plasmid was in the SC form and remained at this level for the remaining 10 hr of the fermentation, allowing adequate time for the harvesting of cells without the loss of supercoiling of product. This study emphasized that optimizing fermentation strategy and identifying the essential nutrients are beneficial for bioprocessing of plasmid DNA for therapeutic applications.
Keywords: Escherichia coli; amino acid starvation; fed-batch; plasmid amplification; semi-defined medium; supercoiling.
© 2019 American Institute of Chemical Engineers.
References
REFERENCES
-
- Wiley. http://www.wiley.com/legacy/wileychi/genmed/clinical/. Accessed August 16, 2018.
-
- Lahijani R, Hulley G, Soriano G, Horn NA, Marquet M. High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. Hum Gene Ther. 1996;7:1971-1980.
-
- Chen W, Graham C, Ciccarelli RB. Automated fed-batch fermentation with feedback controls based on dissolved oxygen (DO) and pH for production of DNA vaccines. J Ind Microbiol Biotechnol. 1997;18:43-48.
-
- Listner K, Bentley L, Okonkowski J, et al. Development of a highly productive and scalable plasmid DNA production platform. Biotechnol Prog. 2006;22:1335-1345.
-
- Prather KJ, Sagar S, Murphy J, Chartrain M. Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production and purification. Enzyme Microb Technol. 2003;33:865-883.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
